. . . . . . . "[APOE epsilon 4 carrier status by itself does not predict cognitive decline or conversion to Alzheimer's disease, indicating that APOE genotyping in patients with mild cognitive impairment may have limited clinical applicability for prediction of outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2009-03-31"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:10:37+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .